Active, not recruitingNCT05153941

Diagnosis and Monitoring of Disease Progression Using Deep Neuro Signatures

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Altoida
Principal Investigator
Sophie Skalidi MD, PhD
General State Hospital of Nikaia "Saint Panteleimon"
Enrollment
3500 target
Eligibility
50 years · All sexes
Timeline
2022 – 2030

Study locations (1)

Collaborators

Eisai Co., Ltd. · Ionian University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05153941 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials